Literature DB >> 18342658

Epstein-Barr virus-associated epithelial and mesenchymal neoplasms.

Andrea T Deyrup1.   

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human pathogen that usually maintains a harmonious relationship with its host. Rarely, this host-virus balance is perturbed, causing a diverse group of malignancies in both immunocompetent and immunosuppressed patients. In addition to its role in hematologic malignancies (Burkitt lymphoma, subsets of Hodgkin and T-cell lymphomas, posttransplant lymphomas), EBV has been implicated in both epithelial (undifferentiated nasopharyngeal carcinoma, a subset of gastric adenocarcinomas) and mesenchymal (EBV-associated smooth muscle tumor, inflammatory pseudotumor-like follicular dendritic cell tumor) neoplasms. This review will focus on EBV-associated epithelial and mesenchymal neoplasms.

Entities:  

Mesh:

Year:  2008        PMID: 18342658     DOI: 10.1016/j.humpath.2007.10.030

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

1.  Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus.

Authors:  Korntip Amornthatree; Hutcha Sriplung; Winyou Mitarnun; Wipawee Nittayananta
Journal:  J Oral Pathol Med       Date:  2011-10-08       Impact factor: 4.253

Review 2.  Multicentric hepatic EBV-associated smooth muscle tumors in an AIDS patient: a case report, investigation of mTOR activation and review of the literature.

Authors:  Qi Shen; Wei Feng; Michael S Long; Xiuzhen Duan; Siraya Jaijakul; Cesar A Arias; Robert E Brown; Bihong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2011-04-23

3.  EBV-associated myoid tumor with lipoblast-like cells in a patient with normal immunity.

Authors:  Ruohao Wu; Wenting Tang; Danxia Tang; Yu Li; Lijuan Bian; Yang Li
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

4.  Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq.

Authors:  Joseph D Khoury; Nizar M Tannir; Michelle D Williams; Yunxin Chen; Hui Yao; Jianping Zhang; Erika J Thompson; Funda Meric-Bernstam; L Jeffrey Medeiros; John N Weinstein; Xiaoping Su
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

5.  Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.

Authors:  Lijuan Hu; Zhirui Lin; Yanheng Wu; Juqin Dong; Bo Zhao; Yanbing Cheng; Peiyu Huang; Lihua Xu; Tianliang Xia; Dan Xiong; Hongbo Wang; Manzhi Li; Ling Guo; Elliott Kieff; Yixin Zeng; Qian Zhong; Musheng Zeng
Journal:  Front Med       Date:  2016-03-11       Impact factor: 4.592

Review 6.  Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.

Authors:  Ravindra Uppaluri; Gavin P Dunn; James S Lewis
Journal:  Cancer Immun       Date:  2008-12-04

7.  Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.

Authors:  Jing Wei; Chen Guo; Xiang An; Wenxuan Miao; Chenli Zhang; Binsheng Wang; Wei Cai; Min Li; Fangfang Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-08-07       Impact factor: 6.730

8.  Head and neck cancer. An aetiopathogenetic study of non-endemic lymphoepithelioma.

Authors:  F G Casco; M J Ríos; M DE Miguel; T González; A M Moreno Fernández; H Galera-Ruiz; R González-Cámpora; R Drut; C Bacchi; H Galera-Davidson
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

9.  Exacerbated metastatic disease in a mouse mammary tumor model following latent gammaherpesvirus infection.

Authors:  Vinita S Chauhan; Daniel A Nelson; Lopamudra Das Roy; Pinku Mukherjee; Kenneth L Bost
Journal:  Infect Agent Cancer       Date:  2012-05-29       Impact factor: 2.965

10.  AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases.

Authors:  Bibianna Purgina; Uma N M Rao; Markku Miettinen; Liron Pantanowitz
Journal:  Patholog Res Int       Date:  2011-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.